Skip to main content
Livermore
Livermore
ZHEN

Avalo Therapeutics, Inc.

AVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534120

In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Avalo Therapeutics, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of AVTX: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3666+30
Shares7.84M15.3M+7.47M (+95.3%)
Value$39.1M$194.7M+$155.5M (+397.4%)

New holders (32)

Institutions that held Avalo Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to AVTX in Q3 2025
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.1,053,983$13.4M0.03%
Caligan Partners LP833,333$10.6M1.47%
Balyasny Asset Management LLC817,436$10.4M0.02%
Silverarc Capital Management, LLC720,922$9.16M1.33%
Citadel Advisors LLC481,669$6.12M0.00%
Adage Capital Partners GP, L.L.C.258,769$3.29M0.01%
Ameriprise Financial Inc213,572$2.71M0.00%
Superstring Capital Management LP188,080$2.39M2.36%
Ally Bridge Group (NY) LLC178,100$2.26M1.90%
Millennium Management LLC137,431$1.75M0.00%
Boxer Capital Management, LLC125,000$1.59M0.51%
Exome Asset Management LLC100,036$1.27M0.84%
Patient Square Capital LP100,000$1.27M0.34%
Renaissance Technologies LLC98,700$1.25M0.00%
Cantor Fitzgerald, L. P.85,247$1.08M0.02%
DLD Asset Management, LP75,000$953.3K0.12%
Standard Life Aberdeen plc72,800$925.3K0.00%
Marshall Wace, LLP56,009$711.9K0.00%
Susquehanna International Group, LLP47,398$602.4K0.00%
State Street Corp45,454$577.7K0.00%
Landscape Capital Management, L.L.C.33,337$423.7K0.03%
Birchview Capital, LP31,000$394.0K0.30%
HighVista Strategies LLC27,778$353.1K0.09%
Prelude Capital Management, LLC24,628$313.0K0.02%
XTX Topco Ltd13,950$177.3K0.01%
Dimensional Fund Advisors LP11,215$143.2K0.00%
Barclays PLC9,346$118.8K0.00%
BIT Capital GmbH1,929$24.5K0.00%
PFS Partners, LLC1,000$12.7K0.01%
Simplex Trading, LLC748$9.00K0.00%
Citigroup Inc400$5.08K0.00%
Tower Research Capital LLC (TRC)26$3300.00%

Sold out (2)

Institutions that held Avalo Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of AVTX in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Allostery Investments LP9,000$44.9K
Raymond James Financial Inc1$5